Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

71%

5 of 7 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 2

3(37.5%)

8Total

N/A(5)

Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05165810Not ApplicableActive Not Recruiting

Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India

Role: collaborator

NCT02969915Not ApplicableCompleted

Strategies to Improve the HIV Care Continuum Among Key Populations in India

Role: collaborator

NCT03645044Active Not Recruiting

Towards a Functional Cure for HBV - The COMMIT Cohort Study

Role: collaborator

NCT04652804Not ApplicableCompleted

Supporting Treatment Outcomes Among PWID

Role: collaborator

NCT03966586Not ApplicableCompleted

Syndemics and Loss from the HIV Care Continuum in India - Intervention

Role: collaborator

NCT03480932Phase 2Completed

Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]

Role: collaborator

NCT02541409Phase 2Completed

Directly Observed Therapy for HCV in Chennai, India

Role: collaborator

NCT01686750Not ApplicableCompleted

Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations

Role: collaborator

NCT01031745Phase 2Completed

Contingency Management in the Delivery of HAART to Drug Users in Chennai, India

Role: collaborator

All 9 trials loaded